# Exela Pharma Sciences LLC - Inspection Records Source: https://www.globalkeysolutions.net/companies/exela-pharma-sciences-llc/4e6f3b32-adeb-41f4-b9dd-a8e7784569b3 > Inspection records and compliance data for Exela Pharma Sciences LLC in Lenoir, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Exela Pharma Sciences LLC - FEI Number: 3008563008 - City: Lenoir - State: North Carolina - Country Name: United States - Address Line 1: 1245 Blowing Rock Blvd - Zip Code: 28645 - Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/60077e2a-4655-4ff7-84ff-713e02f8a6b0) — source: FDA, date: November 15, 2024 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2024-11-15](https://www.globalkeysolutions.net/records/warning_letter/exela-pharma-sciences-llc/832d5d8c-294f-4c3e-9653-35170b74e857) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/7fa0eb4d-d50b-495c-9096-18866220d8af) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/75c7f1e7-b82d-4fec-b497-f6c7b6c3fab8) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/c49bbdca-1ca9-482e-af5f-49658d2feb1c) — classification: Official Action Indicated (OAI), source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-04](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/bc618c55-02a7-4815-8657-992fe5c2d7e4) — source: FDA, date: November 4, 2024 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2019-07-18](https://www.globalkeysolutions.net/records/warning_letter/exela-pharma-sciences-llc/7cf4c257-966b-464d-879f-fd23e25eae1c) — source: FDA, date: July 18, 2019 - [483 - Exela Pharma Sciences LLC - 2019-07-18](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/984bf368-0442-4212-a91a-700be16d89e9) — source: FDA, date: July 18, 2019 - [FDA Inspection 1096634 - Exela Pharma Sciences LLC - 2019-07-18](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/158d466d-f3a8-44b8-83e0-cf8497d372f6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2019 - [483 - Exela Pharma Sciences LLC - 2019-03-29](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/d9a4c4a7-1eb9-418c-958b-e0105fc4cc09) — source: FDA, date: March 29, 2019 - [EIR - Exela Pharma Sciences LLC - 2018-12-19](https://www.globalkeysolutions.net/records/eir/exela-pharma-sciences-llc/46cd4842-57f4-427d-b5ba-3a0d9b0f1ed1) — source: FDA, date: December 19, 2018 - [FDA Inspection 1081405 - Exela Pharma Sciences LLC - 2018-12-19](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/b1e440fb-dc27-4b47-b6cb-b767a36b64d9) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2018 - [145 - Exela Pharma Sciences LLC - 2018-11-18](https://www.globalkeysolutions.net/records/145/exela-pharma-sciences-llc/0661112a-c78c-4762-afe7-844861a51d50) — source: FDA, date: November 18, 2018 - [FDA Inspection 1067755 - Exela Pharma Sciences LLC - 2018-09-11](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/04fb85de-d9ad-4cdf-b407-5e409c65b64c) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2018 - [483 - Exela Pharma Sciences LLC - 2017-09-28](https://www.globalkeysolutions.net/records/483/exela-pharma-sciences-llc/53b07345-0a6d-47a7-a612-27e5c875b226) — source: FDA, date: September 28, 2017 - [FDA Inspection 1026858 - Exela Pharma Sciences LLC - 2017-09-28](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/b2f6d327-c123-48d0-9650-b494e5151266) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2017 - [FDA Inspection 988490 - Exela Pharma Sciences LLC - 2016-06-08](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/2da7002e-f05d-43fa-a427-a0117c3e2ca4) — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2016 - [FDA Inspection 906470 - Exela Pharma Sciences LLC - 2014-11-21](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/3cff58d4-a972-40e4-b2c8-8d44a67b2e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2014 - [FDA Inspection 893626 - Exela Pharma Sciences LLC - 2014-08-28](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/af7923fe-a410-40ce-bb1b-025b2d211ad0) — classification: No Action Indicated (NAI), source: FDA, date: August 28, 2014 - [FDA Inspection 849770 - Exela Pharma Sciences LLC - 2013-04-12](https://www.globalkeysolutions.net/records/fda_inspections/exela-pharma-sciences-llc/7f2bce59-2fd8-4458-9d73-a50ecc686466) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2013 ## Related Companies - [SUNNY PHARMTECH INC.](https://www.globalkeysolutions.net/companies/sunny-pharmtech-inc/ef1ee573-efce-4b46-a67b-b9dfafc78f82) - [Biotest AG](https://www.globalkeysolutions.net/companies/biotest-ag/a9ea8ef4-79ad-47e6-a0a9-c434d0a69869) - [Bavarian Nordic Berna GmbH](https://www.globalkeysolutions.net/companies/bavarian-nordic-berna-gmbh/c041bdf1-c3d5-46c3-a216-02ad314f45e0) - [Juno Therapeutics, Inc.](https://www.globalkeysolutions.net/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35) - [Henogen SRL](https://www.globalkeysolutions.net/companies/henogen-srl/273669c2-3349-41d3-a904-a56d90f76482) - [Lonza Houston, Inc](https://www.globalkeysolutions.net/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6) - [Fujian Genohope Biotech Ltd.](https://www.globalkeysolutions.net/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9) - [Industria Farmaceutica Galenica Senese Srl](https://www.globalkeysolutions.net/companies/industria-farmaceutica-galenica-senese-srl/0d49d76f-5718-4021-a5b5-a3144c3fc1cc) - [Grand River Aseptic Manufacturing Inc.](https://www.globalkeysolutions.net/companies/grand-river-aseptic-manufacturing-inc/f538a5fa-320e-4240-954d-762b7d02795a) - [Lyocontract GmbH](https://www.globalkeysolutions.net/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27) ## Related Officers - [Santos E. Camara](https://www.globalkeysolutions.net/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce) - [ CSO](https://www.globalkeysolutions.net/people/megan-t-ziegler/3e83a317-701a-4e40-bb43-34d294d3448f) - [Investigator](https://www.globalkeysolutions.net/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f) - [Consumer Safety Officer](https://www.globalkeysolutions.net/people/brett-weed/6f999684-d103-423a-ba03-6c70821c53b5) - [ Drug Investigator](https://www.globalkeysolutions.net/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783) - [Jason R. Caballero](https://www.globalkeysolutions.net/people/jason-r-caballero/c2c8d281-0d02-459f-9541-bc04cb6d0a59)